In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis

Peter Melby, Fernando Andrade-Narvaez, Barbara J. Darnell, Guillermo Valencia-Pacheco

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Th1-type cellular immune responses (interferon-γ) play a critical role in protection against Leishmania spp. infection, whereas Th2-type cytokines (interleukin (IL)-4, IL-10) have a counter-protective effect. IL-12, a potent inducer of Th1-type cellular immune responses, may play a pivotal role in the development of a protective response. We found that IL-10 and IL-12 mRNAs were expressed in most lesions of individuals with active cutaneous leishmaniasis. The quantity of IL-12 mRNA was highly variable but correlated strongly with the level of interferon-γ expression. IL-12 expression also paralleled the expression of IL-10, a potent in vitro suppressor of IL-12 and interferon-γ production. The more chronic, non-healing lesions generally had higher levels of IL-12 mRNA indicating that the expression of this cytokine alone was not sufficient to induce healing. Although the in situ production of IL-10 did not appear to block IL-12 expression, IL-10 may still promote disease by direct suppression of macrophage activation.

Original languageEnglish (US)
Pages (from-to)101-107
Number of pages7
JournalFEMS Immunology and Medical Microbiology
Volume15
Issue number2-3
DOIs
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

Cutaneous Leishmaniasis
Interleukin-12
Interleukin-10
Cellular Immunity
Messenger RNA
Interferons
Cytokines
Macrophage Activation
Leishmania
Interleukin-4
Interferon-gamma
Infection

Keywords

  • Cellular immunity
  • Cytokine
  • Interleukin-10
  • Interleukin-12
  • Leishmania
  • Polymerase chain reaction

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Infectious Diseases

Cite this

In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. / Melby, Peter; Andrade-Narvaez, Fernando; Darnell, Barbara J.; Valencia-Pacheco, Guillermo.

In: FEMS Immunology and Medical Microbiology, Vol. 15, No. 2-3, 09.1996, p. 101-107.

Research output: Contribution to journalArticle

Melby, Peter ; Andrade-Narvaez, Fernando ; Darnell, Barbara J. ; Valencia-Pacheco, Guillermo. / In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. In: FEMS Immunology and Medical Microbiology. 1996 ; Vol. 15, No. 2-3. pp. 101-107.
@article{d5e0f1b5df1446ba951343d5d27297ae,
title = "In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis",
abstract = "Th1-type cellular immune responses (interferon-γ) play a critical role in protection against Leishmania spp. infection, whereas Th2-type cytokines (interleukin (IL)-4, IL-10) have a counter-protective effect. IL-12, a potent inducer of Th1-type cellular immune responses, may play a pivotal role in the development of a protective response. We found that IL-10 and IL-12 mRNAs were expressed in most lesions of individuals with active cutaneous leishmaniasis. The quantity of IL-12 mRNA was highly variable but correlated strongly with the level of interferon-γ expression. IL-12 expression also paralleled the expression of IL-10, a potent in vitro suppressor of IL-12 and interferon-γ production. The more chronic, non-healing lesions generally had higher levels of IL-12 mRNA indicating that the expression of this cytokine alone was not sufficient to induce healing. Although the in situ production of IL-10 did not appear to block IL-12 expression, IL-10 may still promote disease by direct suppression of macrophage activation.",
keywords = "Cellular immunity, Cytokine, Interleukin-10, Interleukin-12, Leishmania, Polymerase chain reaction",
author = "Peter Melby and Fernando Andrade-Narvaez and Darnell, {Barbara J.} and Guillermo Valencia-Pacheco",
year = "1996",
month = "9",
doi = "10.1016/0928-8244(96)00047-8",
language = "English (US)",
volume = "15",
pages = "101--107",
journal = "Pathogens and Disease",
issn = "2049-632X",
publisher = "John Wiley & Sons Inc.",
number = "2-3",

}

TY - JOUR

T1 - In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis

AU - Melby, Peter

AU - Andrade-Narvaez, Fernando

AU - Darnell, Barbara J.

AU - Valencia-Pacheco, Guillermo

PY - 1996/9

Y1 - 1996/9

N2 - Th1-type cellular immune responses (interferon-γ) play a critical role in protection against Leishmania spp. infection, whereas Th2-type cytokines (interleukin (IL)-4, IL-10) have a counter-protective effect. IL-12, a potent inducer of Th1-type cellular immune responses, may play a pivotal role in the development of a protective response. We found that IL-10 and IL-12 mRNAs were expressed in most lesions of individuals with active cutaneous leishmaniasis. The quantity of IL-12 mRNA was highly variable but correlated strongly with the level of interferon-γ expression. IL-12 expression also paralleled the expression of IL-10, a potent in vitro suppressor of IL-12 and interferon-γ production. The more chronic, non-healing lesions generally had higher levels of IL-12 mRNA indicating that the expression of this cytokine alone was not sufficient to induce healing. Although the in situ production of IL-10 did not appear to block IL-12 expression, IL-10 may still promote disease by direct suppression of macrophage activation.

AB - Th1-type cellular immune responses (interferon-γ) play a critical role in protection against Leishmania spp. infection, whereas Th2-type cytokines (interleukin (IL)-4, IL-10) have a counter-protective effect. IL-12, a potent inducer of Th1-type cellular immune responses, may play a pivotal role in the development of a protective response. We found that IL-10 and IL-12 mRNAs were expressed in most lesions of individuals with active cutaneous leishmaniasis. The quantity of IL-12 mRNA was highly variable but correlated strongly with the level of interferon-γ expression. IL-12 expression also paralleled the expression of IL-10, a potent in vitro suppressor of IL-12 and interferon-γ production. The more chronic, non-healing lesions generally had higher levels of IL-12 mRNA indicating that the expression of this cytokine alone was not sufficient to induce healing. Although the in situ production of IL-10 did not appear to block IL-12 expression, IL-10 may still promote disease by direct suppression of macrophage activation.

KW - Cellular immunity

KW - Cytokine

KW - Interleukin-10

KW - Interleukin-12

KW - Leishmania

KW - Polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=0030248330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030248330&partnerID=8YFLogxK

U2 - 10.1016/0928-8244(96)00047-8

DO - 10.1016/0928-8244(96)00047-8

M3 - Article

VL - 15

SP - 101

EP - 107

JO - Pathogens and Disease

JF - Pathogens and Disease

SN - 2049-632X

IS - 2-3

ER -